Altimmune, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Altimmune, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Altimmune, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$24.8M, a 9.88% decline year-over-year.
  • Altimmune, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$112M, a 31.1% decline year-over-year.
  • Altimmune, Inc. annual Operating Income (Loss) for 2023 was -$95.9M, a 9.33% decline from 2022.
  • Altimmune, Inc. annual Operating Income (Loss) for 2022 was -$87.7M, a 9.47% increase from 2021.
  • Altimmune, Inc. annual Operating Income (Loss) for 2021 was -$96.9M, a 76.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$112M -$24.8M -$2.23M -9.88% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$110M -$26.7M -$8.74M -48.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$101M -$26.8M -$5.04M -23.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$95.9M -$33.6M -$10.5M -45.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$85.4M -$22.5M +$2.21M +8.94% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$87.6M -$18M +$2.39M +11.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$90M -$21.8M -$2.26M -11.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$87.7M -$23.1M +$891K +3.72% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$88.6M -$24.8M +$8.45M +25.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$97.1M -$20.4M +$4.47M +18% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$102M -$19.5M -$4.64M -31.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$96.9M -$24M -$13.2M -123% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$83.7M -$33.2M -$14.9M -81.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$68.8M -$24.9M -$6.45M -35% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$62.4M -$14.9M -$7.55M -103% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$54.8M -$10.7M -$6.44M -149% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$48.4M -$18.3M -$7.05M -62.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$41.3M -$18.4M -$14.9M -419% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$26.4M -$7.31M -$4.98M -214% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$21.5M -$4.31M +$23M +84.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$44.5M -$11.3M -$7.22M -178% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$37.3M -$3.55M +$1.88M +34.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$39.2M -$2.33M +$3.67M +61.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$42.8M -$27.3M -$14.8M -118% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$28.1M -$4.06M +$26.9M +86.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$54.9M -$5.44M -$1.42M -35.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$53.5M -$5.99M -$1.48M -32.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$52M -$12.6M -$7.05M -128% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$45M -$31M -$26.2M -546% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$18.8M -$4.01M -$2.41M -150% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$16.4M -$4.52M -$3.26M -260% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$13.2M -$5.51M -$4.57M -486% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-14
Q3 2016 -$8.59M -$4.79M -$3.13M -189% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$5.46M -$1.6M +$363K +18.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$5.82M -$1.25M -$2.42M -208% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$3.4M -$940K +$1.68M +64.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$5.09M -$1.66M +$2.34M +58.5% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 -$7.42M -$1.96M -$795K -68% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 -$6.63M $1.16M +$3.56M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 -$10.2M -$2.62M +$2.44M +48.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$12.6M -$4M -$797K -24.9% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-11
Q2 2014 -$11.8M -$1.17M +$312K +21% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-11
Q1 2014 -$12.2M -$2.4M -$1.31M -120% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-11
Q4 2013 -$10.8M -$5.07M -$3.64M -255% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 -$7.2M -$3.2M -$1.41M -78.7% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-11
Q2 2013 -$5.79M -$1.48M -$23.5K -1.61% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-11
Q1 2013 -$5.77M -$1.09M +$500K +31.4% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-11
Q4 2012 -$6.27M -$1.43M -$345K -31.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-11
Q3 2012 -$5.92M -$1.79M +$1.23M +40.8% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-11
Q2 2012 -$7.15M -$1.46M +$1.62M +52.7% Mar 31, 2012 Jun 30, 2012 10-Q 2012-08-07
Q1 2012 -$8.78M -$1.59M +$2.95M +65% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-11
Q4 2011 -$11.7M -$1.08M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 -$3.02M +$343K +10.2% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-14
Q2 2011 -$3.08M +$2.46M +44.4% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-14
Q1 2011 -$4.54M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-14
Q3 2010 -$3.36M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 -$5.54M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.